
Evaluation of the effectiveness and tolerability of sunitinib and pazopanib in the first line treatment of metastatic renal cell carcinoma
Author(s) -
Senar Ebinç,
Ziya Kalkan,
Zeynep Oruç,
Zuhat Urakçı,
Mehmet Küçüköner,
Muhammet Ali Kaplan,
Abdurrahman Işıkdoğan
Publication year - 2022
Publication title -
oncology in clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 2450-6478
pISSN - 2450-1654
DOI - 10.5603/ocp.2021.0033
Subject(s) - pazopanib , sunitinib , medicine , tolerability , renal cell carcinoma , oncology , nausea , adverse effect , urology